Global Drugs for Malaria Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Drugs for Malaria, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs for Malaria, also provides the value of main regions and countries. Of the upcoming market potential for Drugs for Malaria, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Malaria revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Malaria market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Drugs for Malaria company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Drugs for Malaria segment by Company
1. To analyze and research the global Drugs for Malaria status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Drugs for Malaria key companies, revenue, market share, and recent developments.
3. To split the Drugs for Malaria breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Drugs for Malaria market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Drugs for Malaria significant trends, drivers, influence factors in global and regions.
6. To analyze Drugs for Malaria competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Malaria industry.
Chapter 3: Detailed analysis of Drugs for Malaria company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Drugs for Malaria in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Drugs for Malaria in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Drugs for Malaria, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs for Malaria, also provides the value of main regions and countries. Of the upcoming market potential for Drugs for Malaria, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Malaria revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Malaria market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Drugs for Malaria company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Drugs for Malaria segment by Company
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Prevention
- Treatment
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Drugs for Malaria status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Drugs for Malaria key companies, revenue, market share, and recent developments.
3. To split the Drugs for Malaria breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Drugs for Malaria market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Drugs for Malaria significant trends, drivers, influence factors in global and regions.
6. To analyze Drugs for Malaria competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Malaria industry.
Chapter 3: Detailed analysis of Drugs for Malaria company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Drugs for Malaria in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Drugs for Malaria in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Drugs for Malaria Market Size, 2019 VS 2023 VS 2030
1.3 Global Drugs for Malaria Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DRUGS FOR MALARIA MARKET DYNAMICS
2.1 Drugs for Malaria Industry Trends
2.2 Drugs for Malaria Industry Drivers
2.3 Drugs for Malaria Industry Opportunities and Challenges
2.4 Drugs for Malaria Industry Restraints
3 DRUGS FOR MALARIA MARKET BY COMPANY
3.1 Global Drugs for Malaria Company Revenue Ranking in 2023
3.2 Global Drugs for Malaria Revenue by Company (2019-2024)
3.3 Global Drugs for Malaria Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Drugs for Malaria Company Manufacturing Base & Headquarters
3.5 Global Drugs for Malaria Company, Product Type & Application
3.6 Global Drugs for Malaria Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Drugs for Malaria Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 DRUGS FOR MALARIA MARKET BY TYPE
4.1 Drugs for Malaria Type Introduction
4.1.1 Aryl Aminoalcohol Compounds
4.1.2 Antifolate Compounds
4.1.3 Artemisinin Compounds
4.2 Global Drugs for Malaria Sales Value by Type
4.2.1 Global Drugs for Malaria Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Drugs for Malaria Sales Value by Type (2019-2030)
4.2.3 Global Drugs for Malaria Sales Value Share by Type (2019-2030)
5 DRUGS FOR MALARIA MARKET BY APPLICATION
5.1 Drugs for Malaria Application Introduction
5.1.1 Prevention
5.1.2 Treatment
5.1.3 Others
5.2 Global Drugs for Malaria Sales Value by Application
5.2.1 Global Drugs for Malaria Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Drugs for Malaria Sales Value by Application (2019-2030)
5.2.3 Global Drugs for Malaria Sales Value Share by Application (2019-2030)
6 DRUGS FOR MALARIA MARKET BY REGION
6.1 Global Drugs for Malaria Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Drugs for Malaria Sales Value by Region (2019-2030)
6.2.1 Global Drugs for Malaria Sales Value by Region: 2019-2024
6.2.2 Global Drugs for Malaria Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Drugs for Malaria Sales Value (2019-2030)
6.3.2 North America Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drugs for Malaria Sales Value (2019-2030)
6.4.2 Europe Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Drugs for Malaria Sales Value (2019-2030)
6.5.2 Asia-Pacific Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Drugs for Malaria Sales Value (2019-2030)
6.6.2 Latin America Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Drugs for Malaria Sales Value (2019-2030)
6.7.2 Middle East & Africa Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
7 DRUGS FOR MALARIA MARKET BY COUNTRY
7.1 Global Drugs for Malaria Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Drugs for Malaria Sales Value by Country (2019-2030)
7.2.1 Global Drugs for Malaria Sales Value by Country (2019-2024)
7.2.2 Global Drugs for Malaria Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.3.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.4.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.5.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.6.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.7.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.8.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.9.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.10.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.11.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.12.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.13.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.14.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.15.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.16.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.17.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.18.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.19.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.20.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.21.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Cipla
8.1.1 Cipla Comapny Information
8.1.2 Cipla Business Overview
8.1.3 Cipla Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.1.4 Cipla Drugs for Malaria Product Portfolio
8.1.5 Cipla Recent Developments
8.2 Guilin Pharmaceutical
8.2.1 Guilin Pharmaceutical Comapny Information
8.2.2 Guilin Pharmaceutical Business Overview
8.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
8.2.5 Guilin Pharmaceutical Recent Developments
8.3 IPCA Laboratories
8.3.1 IPCA Laboratories Comapny Information
8.3.2 IPCA Laboratories Business Overview
8.3.3 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
8.3.5 IPCA Laboratories Recent Developments
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Comapny Information
8.4.2 GlaxoSmithKline Business Overview
8.4.3 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
8.4.5 GlaxoSmithKline Recent Developments
8.5 Mylan Labs
8.5.1 Mylan Labs Comapny Information
8.5.2 Mylan Labs Business Overview
8.5.3 Mylan Labs Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.5.4 Mylan Labs Drugs for Malaria Product Portfolio
8.5.5 Mylan Labs Recent Developments
8.6 Roche
8.6.1 Roche Comapny Information
8.6.2 Roche Business Overview
8.6.3 Roche Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.6.4 Roche Drugs for Malaria Product Portfolio
8.6.5 Roche Recent Developments
8.7 Novartis
8.7.1 Novartis Comapny Information
8.7.2 Novartis Business Overview
8.7.3 Novartis Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.7.4 Novartis Drugs for Malaria Product Portfolio
8.7.5 Novartis Recent Developments
8.8 Sanofi Aventis
8.8.1 Sanofi Aventis Comapny Information
8.8.2 Sanofi Aventis Business Overview
8.8.3 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
8.8.5 Sanofi Aventis Recent Developments
8.9 Ajanta Pharma
8.9.1 Ajanta Pharma Comapny Information
8.9.2 Ajanta Pharma Business Overview
8.9.3 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
8.9.5 Ajanta Pharma Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Drugs for Malaria Market Size, 2019 VS 2023 VS 2030
1.3 Global Drugs for Malaria Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DRUGS FOR MALARIA MARKET DYNAMICS
2.1 Drugs for Malaria Industry Trends
2.2 Drugs for Malaria Industry Drivers
2.3 Drugs for Malaria Industry Opportunities and Challenges
2.4 Drugs for Malaria Industry Restraints
3 DRUGS FOR MALARIA MARKET BY COMPANY
3.1 Global Drugs for Malaria Company Revenue Ranking in 2023
3.2 Global Drugs for Malaria Revenue by Company (2019-2024)
3.3 Global Drugs for Malaria Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Drugs for Malaria Company Manufacturing Base & Headquarters
3.5 Global Drugs for Malaria Company, Product Type & Application
3.6 Global Drugs for Malaria Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Drugs for Malaria Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 DRUGS FOR MALARIA MARKET BY TYPE
4.1 Drugs for Malaria Type Introduction
4.1.1 Aryl Aminoalcohol Compounds
4.1.2 Antifolate Compounds
4.1.3 Artemisinin Compounds
4.2 Global Drugs for Malaria Sales Value by Type
4.2.1 Global Drugs for Malaria Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Drugs for Malaria Sales Value by Type (2019-2030)
4.2.3 Global Drugs for Malaria Sales Value Share by Type (2019-2030)
5 DRUGS FOR MALARIA MARKET BY APPLICATION
5.1 Drugs for Malaria Application Introduction
5.1.1 Prevention
5.1.2 Treatment
5.1.3 Others
5.2 Global Drugs for Malaria Sales Value by Application
5.2.1 Global Drugs for Malaria Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Drugs for Malaria Sales Value by Application (2019-2030)
5.2.3 Global Drugs for Malaria Sales Value Share by Application (2019-2030)
6 DRUGS FOR MALARIA MARKET BY REGION
6.1 Global Drugs for Malaria Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Drugs for Malaria Sales Value by Region (2019-2030)
6.2.1 Global Drugs for Malaria Sales Value by Region: 2019-2024
6.2.2 Global Drugs for Malaria Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Drugs for Malaria Sales Value (2019-2030)
6.3.2 North America Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drugs for Malaria Sales Value (2019-2030)
6.4.2 Europe Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Drugs for Malaria Sales Value (2019-2030)
6.5.2 Asia-Pacific Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Drugs for Malaria Sales Value (2019-2030)
6.6.2 Latin America Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Drugs for Malaria Sales Value (2019-2030)
6.7.2 Middle East & Africa Drugs for Malaria Sales Value Share by Country, 2023 VS 2030
7 DRUGS FOR MALARIA MARKET BY COUNTRY
7.1 Global Drugs for Malaria Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Drugs for Malaria Sales Value by Country (2019-2030)
7.2.1 Global Drugs for Malaria Sales Value by Country (2019-2024)
7.2.2 Global Drugs for Malaria Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.3.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.4.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.5.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.6.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.7.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.8.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.9.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.10.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.11.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.12.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.13.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.14.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.15.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.16.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.17.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.18.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.19.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.20.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Drugs for Malaria Sales Value Growth Rate (2019-2030)
7.21.2 Global Drugs for Malaria Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Drugs for Malaria Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Cipla
8.1.1 Cipla Comapny Information
8.1.2 Cipla Business Overview
8.1.3 Cipla Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.1.4 Cipla Drugs for Malaria Product Portfolio
8.1.5 Cipla Recent Developments
8.2 Guilin Pharmaceutical
8.2.1 Guilin Pharmaceutical Comapny Information
8.2.2 Guilin Pharmaceutical Business Overview
8.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
8.2.5 Guilin Pharmaceutical Recent Developments
8.3 IPCA Laboratories
8.3.1 IPCA Laboratories Comapny Information
8.3.2 IPCA Laboratories Business Overview
8.3.3 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
8.3.5 IPCA Laboratories Recent Developments
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Comapny Information
8.4.2 GlaxoSmithKline Business Overview
8.4.3 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
8.4.5 GlaxoSmithKline Recent Developments
8.5 Mylan Labs
8.5.1 Mylan Labs Comapny Information
8.5.2 Mylan Labs Business Overview
8.5.3 Mylan Labs Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.5.4 Mylan Labs Drugs for Malaria Product Portfolio
8.5.5 Mylan Labs Recent Developments
8.6 Roche
8.6.1 Roche Comapny Information
8.6.2 Roche Business Overview
8.6.3 Roche Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.6.4 Roche Drugs for Malaria Product Portfolio
8.6.5 Roche Recent Developments
8.7 Novartis
8.7.1 Novartis Comapny Information
8.7.2 Novartis Business Overview
8.7.3 Novartis Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.7.4 Novartis Drugs for Malaria Product Portfolio
8.7.5 Novartis Recent Developments
8.8 Sanofi Aventis
8.8.1 Sanofi Aventis Comapny Information
8.8.2 Sanofi Aventis Business Overview
8.8.3 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
8.8.5 Sanofi Aventis Recent Developments
8.9 Ajanta Pharma
8.9.1 Ajanta Pharma Comapny Information
8.9.2 Ajanta Pharma Business Overview
8.9.3 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (2019-2024)
8.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
8.9.5 Ajanta Pharma Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Drugs for Malaria Industry Trends
Table 2. Drugs for Malaria Industry Drivers
Table 3. Drugs for Malaria Industry Opportunities and Challenges
Table 4. Drugs for Malaria Industry Restraints
Table 5. Global Drugs for Malaria Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Drugs for Malaria Revenue Share by Company (2019-2024)
Table 7. Global Drugs for Malaria Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Drugs for Malaria Key Company Manufacturing Base & Headquarters
Table 9. Global Drugs for Malaria Company, Product Type & Application
Table 10. Global Drugs for Malaria Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Aryl Aminoalcohol Compounds
Table 15. Major Companies of Antifolate Compounds
Table 16. Major Companies of Artemisinin Compounds
Table 17. Global Drugs for Malaria Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 18. Global Drugs for Malaria Sales Value by Type (2019-2024) & (US$ Million)
Table 19. Global Drugs for Malaria Sales Value by Type (2025-2030) & (US$ Million)
Table 20. Global Drugs for Malaria Sales Value Share by Type (2019-2024)
Table 21. Global Drugs for Malaria Sales Value Share by Type (2025-2030)
Table 22. Major Companies of Prevention
Table 23. Major Companies of Treatment
Table 24. Major Companies of Others
Table 25. Global Drugs for Malaria Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Drugs for Malaria Sales Value by Application (2019-2024) & (US$ Million)
Table 27. Global Drugs for Malaria Sales Value by Application (2025-2030) & (US$ Million)
Table 28. Global Drugs for Malaria Sales Value Share by Application (2019-2024)
Table 29. Global Drugs for Malaria Sales Value Share by Application (2025-2030)
Table 30. Global Drugs for Malaria Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Drugs for Malaria Sales Value by Region (2019-2024) & (US$ Million)
Table 32. Global Drugs for Malaria Sales Value Share by Region (2019-2024)
Table 33. Global Drugs for Malaria Sales Value by Region (2025-2030) & (US$ Million)
Table 34. Global Drugs for Malaria Sales Value Share by Region (2025-2030)
Table 35. Global Drugs for Malaria Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Drugs for Malaria Sales Value by Country (2019-2024) & (US$ Million)
Table 37. Global Drugs for Malaria Sales Value Market Share by Country (2019-2024)
Table 38. Global Drugs for Malaria Sales Value by Country (2025-2030) & (US$ Million)
Table 39. Global Drugs for Malaria Sales Value Market Share by Country (2025-2030)
Table 40. Cipla Company Information
Table 41. Cipla Business Overview
Table 42. Cipla Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 43. Cipla Drugs for Malaria Product Portfolio
Table 44. Cipla Recent Development
Table 45. Guilin Pharmaceutical Company Information
Table 46. Guilin Pharmaceutical Business Overview
Table 47. Guilin Pharmaceutical Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 48. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 49. Guilin Pharmaceutical Recent Development
Table 50. IPCA Laboratories Company Information
Table 51. IPCA Laboratories Business Overview
Table 52. IPCA Laboratories Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 53. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 54. IPCA Laboratories Recent Development
Table 55. GlaxoSmithKline Company Information
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 59. GlaxoSmithKline Recent Development
Table 60. Mylan Labs Company Information
Table 61. Mylan Labs Business Overview
Table 62. Mylan Labs Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 63. Mylan Labs Drugs for Malaria Product Portfolio
Table 64. Mylan Labs Recent Development
Table 65. Roche Company Information
Table 66. Roche Business Overview
Table 67. Roche Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Roche Drugs for Malaria Product Portfolio
Table 69. Roche Recent Development
Table 70. Novartis Company Information
Table 71. Novartis Business Overview
Table 72. Novartis Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Novartis Drugs for Malaria Product Portfolio
Table 74. Novartis Recent Development
Table 75. Sanofi Aventis Company Information
Table 76. Sanofi Aventis Business Overview
Table 77. Sanofi Aventis Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 79. Sanofi Aventis Recent Development
Table 80. Ajanta Pharma Company Information
Table 81. Ajanta Pharma Business Overview
Table 82. Ajanta Pharma Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 84. Ajanta Pharma Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Authors List of This Report
Table 87. Secondary Sources
Table 88. Primary Sources
Table 1. Drugs for Malaria Industry Trends
Table 2. Drugs for Malaria Industry Drivers
Table 3. Drugs for Malaria Industry Opportunities and Challenges
Table 4. Drugs for Malaria Industry Restraints
Table 5. Global Drugs for Malaria Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Drugs for Malaria Revenue Share by Company (2019-2024)
Table 7. Global Drugs for Malaria Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Drugs for Malaria Key Company Manufacturing Base & Headquarters
Table 9. Global Drugs for Malaria Company, Product Type & Application
Table 10. Global Drugs for Malaria Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Aryl Aminoalcohol Compounds
Table 15. Major Companies of Antifolate Compounds
Table 16. Major Companies of Artemisinin Compounds
Table 17. Global Drugs for Malaria Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 18. Global Drugs for Malaria Sales Value by Type (2019-2024) & (US$ Million)
Table 19. Global Drugs for Malaria Sales Value by Type (2025-2030) & (US$ Million)
Table 20. Global Drugs for Malaria Sales Value Share by Type (2019-2024)
Table 21. Global Drugs for Malaria Sales Value Share by Type (2025-2030)
Table 22. Major Companies of Prevention
Table 23. Major Companies of Treatment
Table 24. Major Companies of Others
Table 25. Global Drugs for Malaria Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Drugs for Malaria Sales Value by Application (2019-2024) & (US$ Million)
Table 27. Global Drugs for Malaria Sales Value by Application (2025-2030) & (US$ Million)
Table 28. Global Drugs for Malaria Sales Value Share by Application (2019-2024)
Table 29. Global Drugs for Malaria Sales Value Share by Application (2025-2030)
Table 30. Global Drugs for Malaria Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Drugs for Malaria Sales Value by Region (2019-2024) & (US$ Million)
Table 32. Global Drugs for Malaria Sales Value Share by Region (2019-2024)
Table 33. Global Drugs for Malaria Sales Value by Region (2025-2030) & (US$ Million)
Table 34. Global Drugs for Malaria Sales Value Share by Region (2025-2030)
Table 35. Global Drugs for Malaria Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Drugs for Malaria Sales Value by Country (2019-2024) & (US$ Million)
Table 37. Global Drugs for Malaria Sales Value Market Share by Country (2019-2024)
Table 38. Global Drugs for Malaria Sales Value by Country (2025-2030) & (US$ Million)
Table 39. Global Drugs for Malaria Sales Value Market Share by Country (2025-2030)
Table 40. Cipla Company Information
Table 41. Cipla Business Overview
Table 42. Cipla Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 43. Cipla Drugs for Malaria Product Portfolio
Table 44. Cipla Recent Development
Table 45. Guilin Pharmaceutical Company Information
Table 46. Guilin Pharmaceutical Business Overview
Table 47. Guilin Pharmaceutical Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 48. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 49. Guilin Pharmaceutical Recent Development
Table 50. IPCA Laboratories Company Information
Table 51. IPCA Laboratories Business Overview
Table 52. IPCA Laboratories Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 53. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 54. IPCA Laboratories Recent Development
Table 55. GlaxoSmithKline Company Information
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 59. GlaxoSmithKline Recent Development
Table 60. Mylan Labs Company Information
Table 61. Mylan Labs Business Overview
Table 62. Mylan Labs Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 63. Mylan Labs Drugs for Malaria Product Portfolio
Table 64. Mylan Labs Recent Development
Table 65. Roche Company Information
Table 66. Roche Business Overview
Table 67. Roche Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Roche Drugs for Malaria Product Portfolio
Table 69. Roche Recent Development
Table 70. Novartis Company Information
Table 71. Novartis Business Overview
Table 72. Novartis Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Novartis Drugs for Malaria Product Portfolio
Table 74. Novartis Recent Development
Table 75. Sanofi Aventis Company Information
Table 76. Sanofi Aventis Business Overview
Table 77. Sanofi Aventis Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 79. Sanofi Aventis Recent Development
Table 80. Ajanta Pharma Company Information
Table 81. Ajanta Pharma Business Overview
Table 82. Ajanta Pharma Drugs for Malaria Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 84. Ajanta Pharma Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Authors List of This Report
Table 87. Secondary Sources
Table 88. Primary Sources
LIST OF FIGURES
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drugs for Malaria Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Aryl Aminoalcohol Compounds Picture
Figure 8. Antifolate Compounds Picture
Figure 9. Artemisinin Compounds Picture
Figure 10. Global Drugs for Malaria Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Drugs for Malaria Sales Value Share 2019 VS 2023 VS 2030
Figure 12. Global Drugs for Malaria Sales Value Share by Type (2019-2030)
Figure 13. Prevention Picture
Figure 14. Treatment Picture
Figure 15. Others Picture
Figure 16. Global Drugs for Malaria Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Drugs for Malaria Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Drugs for Malaria Sales Value Share by Application (2019-2030)
Figure 19. Global Drugs for Malaria Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Drugs for Malaria Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 21. North America Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 23. Europe Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Asia-Pacific Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia-Pacific Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Latin America Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 28. Latin America Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 31. USA Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 32. USA Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 33. USA Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 34. Canada Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 35. Canada Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 36. Canada Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 37. Germany Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 38. Germany Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 39. Germany Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 40. France Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. France Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. France Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. U.K. Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. U.K. Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. U.K. Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Italy Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Italy Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Italy Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Netherlands Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Netherlands Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. Netherlands Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. Nordic Countries Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. Nordic Countries Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. Nordic Countries Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. China Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. China Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. China Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Japan Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Japan Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Japan Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. South Korea Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. South Korea Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. South Korea Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. Southeast Asia Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. Southeast Asia Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. Southeast Asia Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. India Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. India Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. India Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. Australia Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. Australia Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. Australia Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Mexico Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Mexico Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Mexico Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. Brazil Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. Brazil Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. Brazil Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Turkey Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Turkey Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Turkey Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Saudi Arabia Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Saudi Arabia Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Saudi Arabia Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. UAE Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. UAE Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. UAE Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Years Considered
Figure 89. Research Process
Figure 90. Key Executives Interviewed
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drugs for Malaria Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Aryl Aminoalcohol Compounds Picture
Figure 8. Antifolate Compounds Picture
Figure 9. Artemisinin Compounds Picture
Figure 10. Global Drugs for Malaria Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Drugs for Malaria Sales Value Share 2019 VS 2023 VS 2030
Figure 12. Global Drugs for Malaria Sales Value Share by Type (2019-2030)
Figure 13. Prevention Picture
Figure 14. Treatment Picture
Figure 15. Others Picture
Figure 16. Global Drugs for Malaria Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Drugs for Malaria Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Drugs for Malaria Sales Value Share by Application (2019-2030)
Figure 19. Global Drugs for Malaria Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Drugs for Malaria Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 21. North America Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 23. Europe Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Asia-Pacific Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia-Pacific Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Latin America Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 28. Latin America Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Drugs for Malaria Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Drugs for Malaria Sales Value Share by Country (%), 2023 VS 2030
Figure 31. USA Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 32. USA Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 33. USA Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 34. Canada Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 35. Canada Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 36. Canada Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 37. Germany Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 38. Germany Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 39. Germany Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 40. France Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. France Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. France Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. U.K. Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. U.K. Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. U.K. Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Italy Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Italy Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Italy Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Netherlands Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Netherlands Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. Netherlands Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. Nordic Countries Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. Nordic Countries Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. Nordic Countries Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. China Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. China Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. China Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Japan Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Japan Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Japan Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. South Korea Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. South Korea Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. South Korea Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. Southeast Asia Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. Southeast Asia Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. Southeast Asia Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. India Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. India Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. India Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. Australia Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. Australia Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. Australia Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Mexico Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Mexico Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Mexico Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. Brazil Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. Brazil Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. Brazil Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Turkey Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Turkey Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Turkey Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Saudi Arabia Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Saudi Arabia Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Saudi Arabia Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. UAE Drugs for Malaria Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. UAE Drugs for Malaria Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. UAE Drugs for Malaria Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Years Considered
Figure 89. Research Process
Figure 90. Key Executives Interviewed
